Stocks · Health care · Pharmaceutical Preparations

COLLEGIUM PHARMACEUTICAL, INC

COLL Clue Score59
United States Fiscal year ends December CIK 0001267565 Results filed 5 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
John Gordon Freund
15 May 2026
Director
Sold after exercise
4,127
$34.54
$142.55K
Garen G Bohlin
11 May 2026
Director
Sold after exercise
8,700
$37.18
$323.49K
Scott Dreyer
8 Dec 2025
EVP & Chief Commercial Officer
Sold after exercise
6,475
$48.66
$315.08K
Scott Dreyer
8 Dec 2025
EVP & Chief Commercial Officer
Sold after exercise
11,125
$47.89
$532.77K
John A. Fallon
12 Nov 2025
Director
Sold after exercise
34,853
$47.21
$1.65M

What was left out

Form 4 filings counted 25
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 5
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 556,864
History held since 13 May 2015